DPP4 and diabetes mellitus: Tahara et al. (2009) performed a comparative study investigating the antidiabetic potency and duration of several DPP-4 inhibitors (0.1–3 mg/kg) in rats with mild diabetes (streptozotocin-nicotinamide-induced models) [277].